Medicare Benefits Schedule item numbers for transcranial magnetic stimulation (TMS): Questions arising

Objective Four Medicare Benefits Schedule item numbers for Transcranial Magnetic Stimulation (TMS) treatment of unresponsive MDD were declared in Australia in 2021. They are accompanied by rules/conditions. The aim is to consider these rules/conditions in light of recent research and real-world experience. Conclusions While evidence supports some listed rules/conditions, others lack clinical justification and deserve to be reconsidered. These include (a) ineligibility of patients who have previously received TMS, (b) a lifetime total limit of 50 treatments, (c) a second/final course being unavailable for 4 months following the completion of the first course, and (d) the second/final course being limited to 15 treatments.

[1]  S. Pridmore,et al.  One Hundred Courses of Cluster Maintenance Transcranial Magnetic Stimulation (CM TMS)-A Clinical Audit Study. , 2022, Psychopharmacology bulletin.

[2]  L. Carpenter,et al.  Systematic review of preservation TMS that includes continuation, maintenance, relapse-prevention, and rescue TMS. , 2021, Journal of affective disorders.

[3]  M. George,et al.  The evidence is in: Repetitive transcranial magnetic stimulation is an effective, safe and well-tolerated treatment for patients with major depressive disorder , 2021, The Australian and New Zealand journal of psychiatry.

[4]  Liqian Cui,et al.  Comparative efficacy and acceptability of neuromodulation procedures in the treatment of treatment-resistant depression: a network meta-analysis of randomized controlled trials. , 2021, Journal of affective disorders.

[5]  P. Coyte,et al.  Cost–Utility Analysis of Electroconvulsive Therapy and Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression in Ontario , 2019, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[6]  W. Pridmore,et al.  Why should we provide transcranial magnetic stimulation (TMS)? , 2019, Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists.

[7]  S. Pridmore,et al.  Second Courses of Transcranial Magnetic Stimulation (TMS) in Major Depressive Episodes for Initial Responders and Non-Responders , 2019, The Malaysian journal of medical sciences : MJMS.

[8]  Á. Pascual-Leone,et al.  Durability of antidepressant response to repetitive transcranial magnetic stimulation: Systematic review and meta-analysis , 2019, Brain Stimulation.

[9]  D. McLoughlin,et al.  Relapse Following Successful Electroconvulsive Therapy for Major Depression: A Meta-Analysis , 2013, Neuropsychopharmacology.

[10]  P. Fitzgerald,et al.  rTMS Treatment for Depression: A Practical Guide , 2022 .